Stevanato Group SpA STVN 深 沪
已收盘 02-06 16:00:00 美东时间
15.50
+1.350
+9.54%
华盛通- 最 高15.63
- 今 开14.51
- 成交量 88.17万股
- 最 低 14.40
- 昨 收 14.15
- 总市值 42.32亿
- 52周最高 28.00
- 市盈率 静 32.99
- 换手率 0.32%
- 52周最低 13.91
- 委 比 0.00%
- 总股本 2.73亿
- 历史最高 36.1811
- 量 比 0.75
- 振 幅 8.69%
- 历史最低 13.1273
- 每 手 1
- 风险率 2.52%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 最高500美元！MongoDB获18家大行紧急上调目标价；巴克莱下调理想汽车目标价至18美元
今日重点评级关注：B. Riley证券：维持Seabridge Gold"买入"评级，目标价从50美元升至65美元；HC Wainwright & Co.：维持TRX Gold"买入"评级，目标价从1.2美元升至1.4美元
2025-12-03 09:58
Morgan Stanley Maintains Equal-Weight on Stevanato Group, Lowers Price Target to $24
Morgan Stanley analyst Tejas Savant maintains Stevanato Group (NYSE:STVN) with a Equal-Weight and lowers the price target from $26 to $24.
2025-12-03 01:56
美股大行评级 | CoreWeave、Monday遭美银、小摩等多家大行下调目标价；中金首予Nebius "跑赢大市"评级，目标价143美元
今日重点评级关注：Piper Sandler：维持MeiraGTx Hldgs"超配"评级，目标价从28美元升至30美元；RBC Capital：维持4D Molecular Therapeutics"跑赢大市"评级，目标价从26美元升至32美元
2025-11-12 11:43
Stevanato Group shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY25 sales guidance above estimates.
Stevanato Group shares are trading higher after the company reported better-tha...
2025-11-06 21:39
Stevanato Group Raises FY2025 Adj EPS Guidance from $0.53-$0.57 to $0.58-$0.63 vs $0.61 Est; Raises FY2025 Sales Guidance from $1.238B-$1.270B to $1.391B vs $1.360B Est
Stevanato Group (NYSE:STVN) raises FY2025 Adj EPS guidance from $0.53-$0.57 to $0.58-$0.63 vs $0.61 analyst estimate. Raises FY2025 sales outlook from $1.238 billion-$1.270 billion to $1.391 billion vs $1.360 billion
2025-11-06 19:43
Stevanato Gr Q3 Adj. EPS $0.16 Beats $0.14 Estimate, Sales $354.507M Beat $335.830M Estimate
Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.14 by 14.29 percent. This is a 23.08 percent increase over earnings of $0.13 per share from the same
2025-11-06 19:31
Stevanato Group Expands German Facility To Boost Drug Delivery Device Production And Strengthen Global Pharma Supply Chain
Stevanato Group S.p.A. (NYSE:STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced a significant
2025-10-21 18:36
Stevanato Group shares are trading lower following the release of its Q2 financial results.
Stevanato Group shares are trading lower following the release of its Q2 financ...
2025-08-06 02:02
Stevanato Group Affirms FY2025 Adj EPS Guidance of $0.53-$0.57 vs $0.53 Est; Affirms FY2025 Sales Guidance of $1.238B-$1.270B vs $1.177B Est
Stevanato Group (NYSE:STVN) affirms FY2025 Adj EPS guidance from $0.53-$0.57 to $0.53-$0.57 vs $0.53 analyst estimate. Affirms FY2025 sales outlook from $1.238 billion-$1.270 billion to $1.238 billion-$1.270 billion vs
2025-08-05 18:34
